The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
Aclaris Therapeutics, Inc. | COM | 00461U105 | 7,689 | 529,551 | SH | SOLE | 529,551 | 0 | 0 | ||
Alder BioPharmaceuticals, Inc. | COM | 014339105 | 16,665 | 1,000,919 | SH | SOLE | 1,000,919 | 0 | 0 | ||
Arbutus Biopharma Corporation | COM | 03879J100 | 25,296 | 2,676,825 | SH | SOLE | 2,676,825 | 0 | 0 | ||
Arcus Biosciences, Inc. | COM | 03969F109 | 4,112 | 295,000 | SH | SOLE | 295,000 | 0 | 0 | ||
Ascendis Pharma A/S | SPONSORED ADR | 04351P101 | 17,391 | 245,424 | SH | SOLE | 245,424 | 0 | 0 | ||
Biohaven Pharmaceutical Holding Company Ltd. | COM | G11196105 | 31,963 | 851,200 | SH | SOLE | 851,200 | 0 | 0 | ||
Crinetics Pharmaceuticals, Inc. | COM | 22663K107 | 1,421 | 49,600 | SH | SOLE | 49,600 | 0 | 0 | ||
CymaBay Therapeutics, Inc. | COM | 23257D103 | 22,419 | 2,023,369 | SH | SOLE | 2,023,369 | 0 | 0 | ||
Eidos Therapeutics, Inc. | COM | 28249H104 | 5,240 | 525,000 | SH | SOLE | 525,000 | 0 | 0 | ||
Gritstone Oncology, Inc. | COM | 39868T105 | 2,492 | 175,000 | SH | SOLE | 175,000 | 0 | 0 | ||
Immunomedics, Inc. | COM | 452907108 | 25,653 | 1,231,543 | SH | SOLE | 1,231,543 | 0 | 0 | ||
Insmed Incorporated | COM | 457669307 | 36,408 | 1,800,587 | SH | SOLE | 1,800,587 | 0 | 0 | ||
Kiniksa Pharmaceuticals, Ltd. | Class A Common | G5269C101 | 2,409 | 94,477 | SH | SOLE | 94,477 | 0 | 0 | ||
Myokardia, Inc. | COM | 62857M105 | 33,333 | 511,244 | SH | SOLE | 511,244 | 0 | 0 | ||
Omeros Corp. | COM | 682143102 | 8,690 | 356,000 | SH | SOLE | 356,000 | 0 | 0 | ||
OptiNose, Inc. | COM | 68404V100 | 18,130 | 1,458,545 | SH | SOLE | 1,458,545 | 0 | 0 | ||
Replimune Group, Inc. | COM | 76029N106 | 19,797 | 1,229,656 | SH | SOLE | 1,229,656 | 0 | 0 | ||
Rhythm Pharmaceuticals, Inc. | COM | 76243J105 | 20,329 | 696,903 | SH | SOLE | 696,903 | 0 | 0 | ||
uniQure N.V. | SHS | N90064101 | 388 | 10,650 | SH | SOLE | 10,650 | 0 | 0 | ||
Verona Pharma Plc | SPONSORED ADS | 925050106 | 104 | 8,302 | SH | SOLE | 8,302 | 0 | 0 | ||
Xenon Pharmaceuticals, Inc. | COM | 98420N105 | 5,091 | 385,714 | SH | SOLE | 385,714 | 0 | 0 |